|
MCL1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.64272999999548E-05 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.97910000000157E-05 |
| Normal-vs-Stage2 |
9.12580000456131E-08 |
| Normal-vs-Stage3 |
2.47549999998764E-06 |
| Normal-vs-Stage4 |
2.3018999999902E-05 |
| Stage1-vs-Stage2 |
5.681400E-03 |
| Stage1-vs-Stage3 |
6.789600E-02 |
| Stage1-vs-Stage4 |
2.798400E-01 |
| Stage2-vs-Stage3 |
6.681700E-02 |
| Stage2-vs-Stage4 |
4.923800E-02 |
| Stage3-vs-Stage4 |
6.838800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.61129999999688E-05 |
| Normal-vs-AfricanAmerican |
1.133540E-02 |
| Normal-vs-Asian |
3.50030000000334E-05 |
| Caucasian-vs-AfricanAmerican |
3.249200E-01 |
| Caucasian-vs-Asian |
4.464400E-01 |
| AfricanAmerican-vs-Asian |
1.139980E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
8.90789999985486E-07 |
| Normal-vs-Female |
3.76970000000032E-05 |
| Male-vs-Female |
4.338200E-02 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.420600E-04 |
| Normal-vs-Age(41-60Yrs) |
2.34389999997919E-06 |
| Normal-vs-Age(61-80Yrs) |
1.45939999973699E-07 |
| Normal-vs-Age(81-100Yrs) |
8.173800E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.670130E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.022700E-04 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.207000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.231370E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.999200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.605200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.469620E-02 |
| Classical-VS-Follicular |
1.5858299999949E-05 |
| Classical-VS-Other |
3.447400E-01 |
| Classical-VS-Normal |
2.373500E-04 |
| Tall-VS-Follicular |
7.397900E-02 |
| Tall-VS-Other |
8.429600E-01 |
| Tall-VS-Normal |
2.9566999999453E-06 |
| Follicular-VS-Other |
6.105000E-01 |
| Follicular-VS-Normal |
4.75210000239201E-08 |
| Other-VS-Normal |
3.620000E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.3730999998417E-07 |
| Normal-vs-N1 |
1.803040E-04 |
| N0-vs-N1 |
4.174100E-02 |
|
|
